Milestone Scientific has launched the first phase of its artificial intelligence strategy with the pilot debut of Milo, an AI-enabled digital engagement platform, at the American Society of Pain and Neuroscience Annual Conference in Miami Beach. Milo is designed to answer product questions, provide educational information, collect customer data, assist with lead qualification, and connect healthcare professionals with sales and support teams. The company plans to use feedback from the ASPN pilot to guide future development, with a broader vision of integrating software, data, and AI across commercial and customer support activities. The platform is part of a strategy focused on customer engagement, commercial excellence, clinical innovation, and a connected MedTech ecosystem.
Milestone ScientificLaunches AI platform Milo at ASPN 2026, enhancing customer engagement and lead qualification
Salesforce.com Inc